ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 082

Anti-Mitochondrial Autoantibodies Are Associated with Dysphagia in Juvenile and Adult Myositis, and with Persistent Weakness and Cardiomyopathy in Adult Myositis

Sara Sabbagh1, Iago Pinal-Fernandez 2, Maria Casal-Dominguez 3, Frederick W. Miller 4, Lisa G. Rider 5, Andrew Mammen 3 and Lisa Christopher-Stine 6, 1NIH/NIAMS, Bethesda, 2National Institutes of Health, Bethesda, 3NIH, Bethesda, 4Bethesda, 5NIEHS, NIH, Garrett Park, 6Johns Hopkins University, Baltimore

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: anti-mitochondria antibody, juvenile dermatomyositis, Myositis

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Session Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in both juvenile-(JM) and adult-onset myositis cohorts and investigated phenotype differences between juvenile and adult myositis patients with or without AMA.

Methods: We screened sera from myositis patients who were classified as dermatomyositis (DM), polymyositis (PM), or inclusion body myositis (IBM) based on Bohan and Peter or Grigg criteria, including 342 juvenile-onset (JM) and 619 adult-onset patients (216 DM, 222 PM, 140 IBM, and 19 amyopathic DM (ADM)), and from healthy controls, including 92 children and 164 adults, for AMA by ELISA. Clinical characteristics were compared between myositis patients with and without AMA.

Results: AMA were present in 1% (4/342) of JM patients, 5% (32/619) of adult myositis patients (16 DM, 10 PM, 4 IBM, and 1 ADM), and 1% of both juvenile and adult healthy controls. Of the 4 JM patients with AMA, 3 had DM and 1 had PM. Three of the four AMA+ JM patients had dysphagia and all 4 patients had a moderate to severe disease onset. There were no other clinical features or medication usage associated with AMA in JM patients. In the 619 adult myositis patients, AMA were associated with cardiomyopathy (16% vs 5%, p=0.01). Additional clinical data available in 480 of the 619 patients followed longitudinally showed that AMA were associated with persistent muscle weakness over an average of 6 visits (90% vs 62%, p=0.005), Raynaud’s phenomenon (43% vs 14%, p< 0.001), and dysphagia (63% vs 36%, p=0.003). Adult patients with AMA also more frequently received glucocorticoids (90% vs 67%, p=0.04) and intravenous immunoglobulin (60% vs 29%, p=0.003).

Conclusion: AMA are present in 1% of JM and 5% of adult myositis patients. In juvenile myositis AMA are not disease specific; however, patients often had dysphagia similar to adult-onset myositis patients with AMA. In adult-onset myositis patients, AMA are also associated with chronic muscle weakness, cardiomyopathy and Raynaud’s. Our data suggest that AMA may have a role in disease management in myositis, and their presence necessitates cardiomyopathy screening in adult-onset, but not juvenile-onset myositis patients.


Disclosure: S. Sabbagh, None; I. Pinal-Fernandez, None; M. Casal-Dominguez, None; F. Miller, None; L. Rider, None; A. Mammen, None; L. Christopher-Stine, None.

To cite this abstract in AMA style:

Sabbagh S, Pinal-Fernandez I, Casal-Dominguez M, Miller F, Rider L, Mammen A, Christopher-Stine L. Anti-Mitochondrial Autoantibodies Are Associated with Dysphagia in Juvenile and Adult Myositis, and with Persistent Weakness and Cardiomyopathy in Adult Myositis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/anti-mitochondrial-autoantibodies-are-associated-with-dysphagia-in-juvenile-and-adult-myositis-and-with-persistent-weakness-and-cardiomyopathy-in-adult-myositis/. Accessed March 28, 2023.
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-mitochondrial-autoantibodies-are-associated-with-dysphagia-in-juvenile-and-adult-myositis-and-with-persistent-weakness-and-cardiomyopathy-in-adult-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences